plied to a Sephadex LH-20 column and then eluted with MeOH. For further purification, the active fraction was purified by reverse-phase HPLC column chromatography via elution with CH 3 OH-H 2 O (90 : 10) at a flow rate of 6 ml/min, which yielded compound 3 (4.4 mg) at a retention time of 22.7 min. 
Assay of AChE and BuChE
The inhibitory activities against AChE were evaluated according to Ellman's coupled enzyme assay 13) with the following modifications; 0.08 units AChE dissolved in 0.1 M potassium phosphate buffer (pH 7.4) and 5 ml of ethanol extracts of plants or methanol solution of purified compounds were added to each well of a 96-well plate. After incubation for 3 min, ATCh and DTNB dissolved in 0.1 M potassium phosphate buffer (pH 7.4) were added to final concentrations of 20 mM and 30 mM, respectively, in each well. The reaction was carried out at room temperature for 5 min, and the initial rate of the enzyme was analyzed by measuring the formation of 5-thio-2-nitrobenzoate, yellow anion at 412 nm of UV wavelength with a microplate reader (Molecular Devices Co., Ltd.). Values for percentages of inhibition were calculated relative to a control sample. The inhibitory activities against BuChE were measured as described above for AChE, using 0.16 unit BuChE and 20 mM BuTCh instead of AChE and ATCh as the enzyme and substrate, respectively.
RESULTS AND DISCUSSION
The ethanol extract of C. majus L. inhibited AChE by 98% at a concentration of 200 mg/ml without significant inhibition (13% inhibition) of BuChE. To isolate the AChE inhibitory constituents of C. majus L., the methanolic extract was suspended in H 2 O and partitioned with chloroform. Therefore, the activity was found in the chloroform fraction. Using several chromatographic methods, compounds 1-3, along with the inactive compound 4, were isolated as active constituents.
The structures of compounds 1-4 were independently determined by mass and NMR studies, since the structures of compounds 1-3 were quite complex. Compounds 1-4 were identified to be 8-hydroxydihydrochelerythrine, 14) 8-hydroxydihydrosanguinarine, 15) noroxyhydrastinine, 16) and berberine, 17) respectively, which mass and NMR spectral data Vol. 29, No. 11 were identical with those of published values. The physicochemical properties of compound 1 and the 13 C-NMR assignments of compounds 1 and 4 were reported for the first time in this study. Chelerythrine and sanguinarine were known to be quite susceptible to nucleophilic attack at C-8, 18) and sanguinarine can be converted to either the 8-hydroxysanguinarine or the pseudomethanolate sanguinarine depending on the environment. 19) The optical rotation of compounds 1 [ϩ8.5°(cϭ0.1, MeOH)] and 2 [Ϫ2.5°(cϭ0.16, MeOH)] suggested that they are probably unequal mixtures of enantiomers like the reported 8-hydroxydihydrosanguinarine [Ϫ9°(cϭ0.4, MeOH)]. 15) The AChE inhibitory activities of compounds 1-4 were determined using Ellman's coupled enzyme assay. As shown in Fig. 2, compounds 1-3 strongly inhibited AChE in a dose-dependent manner, with IC 50 (mM) values of 0.61, 1.37, and 1.85, respectively, while tacrine, an anti-dementia drug that is currently used, inhibited AChE activity with an IC 50 (mM) value of 0.12. To determine the selectivity of compounds 1-4 for AChE, their inhibitory activity on BuChE was assayed (Table 1) . Compounds 1-3 exhibited selective inhibition for AChE compared with BuChE, with selectivities of 56.7, 9.3, and 42.6, respectively, while tacrine had low selectivity with a stronger inhibitory activity on BuChE than AChE in this assay system. The kinetic analysis of AChE inhibition of compound 1 is shown in Fig. 3 . Compound 1 inhibited AChE in a competitive manner with the substrate ATCh. The K i and K m values for AChE were 2.5ϫ10 Ϫ7 M and 2.3ϫ10 Ϫ3 M, respectively. The inhibitory activity selective for AChE of the ethanol extract of C. majus L., was reported in this study for the first time. 8-Hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine, which were isolated from Toddalia asiatica 14) and Dactylicapnos torulosa, 15) respectively, were isolated from C. majus L. and reported for the first time in this study. Additionally, the strong AChE inhibitory activity of 8-hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine was also reported for the first time in this study. Berberine, however, had been known as one of the AChE inhibitors isolated from C. blueneaman 11) and C. speciosa.
12)
Since C. majus L. has been traditionally used as an herbal medicine in Asian and European countries, the extracts of the aerial portions of C. majus L., as well as its active components, 8-hydroxydihydrochelerythrine and 8-hydroxydihydrosanguinarine, may be useful as alternatives for anti-dementia neutraceuticals or currently used agents. 
